Neuronal nicotinic acetylcholine receptor–cholesterol crosstalk in Alzheimer's disease
- 13 November 2009
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 584 (9) , 1856-1863
- https://doi.org/10.1016/j.febslet.2009.11.036
Abstract
Alzheimer's disease (AD) is one of the most devastating diseases of the central nervous system (CNS). It is characterized by two neuropathological findings: amyloid plaques and neurofibrillary tangles. AD is also accompanied by an extensive functional deficit in the cholinergic system, involving the neuronal‐type nicotinic acetylcholine receptor (AChR). Furthermore there is increasing evidence showing a misregulation of cholesterol metabolism in the development of the disease. Since cholesterol affects AChR protein at multiple levels, the cognitive impairment and other neurological correlates of AD might be partly associated with an abnormal crosstalk between the receptor protein and the sterol in this synaptopathy.Keywords
Funding Information
- Ministry of Science and Technology (PICT 5-20155)
- National Science and Technology Research Council (PIP No. 6367)
- Philip Morris USA Inc.
- Philip Morris International
This publication has 90 references indexed in Scilit:
- Deletion of the 7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's DiseaseJournal of Neuroscience, 2009
- EphB Receptors Co-Distribute with a Nicotinic Receptor Subtype and Regulate Nicotinic Downstream Signaling in NeuronsMolecular and Cellular Neuroscience, 2008
- Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ productionNeurobiology of Disease, 2007
- Structural Determinates for Apolipoprotein E-Derived Peptide Interaction with the α7 Nicotinic Acetylcholine ReceptorMolecular Pharmacology, 2007
- Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1Neuron, 2007
- Common genetic variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and late-onset Alzheimer's diseaseProceedings of the National Academy of Sciences, 2007
- Mice thrive without Cdk4 and Cdk2Molecular Oncology, 2007
- ABCA1 polymorphisms and Alzheimer's diseaseNeuroscience Letters, 2007
- Developmental Regulation of Amyloid Precursor Protein at the Neuromuscular Junction in Mouse Skeletal MuscleMolecular and Cellular Neuroscience, 2000
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993